
Migtor 25mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Miglitol (25mg)
Overview Migtor 25mg Tablet
Diabetol 25mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. It's prescribed when dietary changes and other antidiabetic medications prove insufficient to maintain healthy blood glucose levels. Administer Diabetol 25mg immediately before or with the initial bite of a meal. Dosage frequency is determined individually by your physician to optimize glycemic control, potentially increasing gradually. Discontinuing treatment without medical guidance risks elevated blood sugar and severe complications, including renal impairment and visual disturbances. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported side effects include skin eruptions, flatulence, abdominal discomfort, and loose stools; consult your doctor if these persist or are bothersome. While Diabetol 25mg alone doesn't induce hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective. Inform your physician of any hepatic or renal issues prior to commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease, ulcerative colitis). Pregnant or lactating individuals should seek medical counsel before use. Always disclose all concurrent medications to ensure safe usage. Limit alcohol consumption as it may heighten hypoglycemia risk.
Primary Ingredients of Migtor 25mg Tablet
There is no text provided to rephrase.
Uses of Migtor 25mg Tablet
Managing type 2 diabetes
Major Benefits of Migtor 25mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 25mg Migtor tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken with food.
Common Side effects of Migtor 25mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Migtor 25mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Migtor 25mg tablets should be administered with a meal.
How Migtor 25mg Tablet works:
GlucoReg 25mg tablets are an antihyperglycemic medication. By suppressing intestinal enzymes that digest complex carbohydrates, they reduce postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Migtor 25mg tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Migtor 25mg Tablets during pregnancy is generally regarded as safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Migtor 25mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Migtor 25mg Tablets.
KidneyCAUTION
Exercise caution when administering Migtor 25mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Migtor 25mg tablets are contraindicated in patients exhibiting severe renal insufficiency.
LiverSAFE IF PRESCRIBED
Use of Migtor 25mg tablets in patients with liver disease is likely safe. Available evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Migtor 25mg Tablet :
Omit any missed Migtor 25mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Migtor 25mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Nojirimycin Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
